Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-10-11
1993-08-17
Fan, Jane T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514322, 5142345, 514866, A61K 31415
Patent
active
052369455
ABSTRACT:
Abstract Certain 1H-indazole-3-acetic acid derivatives, and their pharmaceutically-acceptable esters and salts, are inhibitors of the aldose reductase enzyme, and so are useful in the treatment of diabetic complications.
REFERENCES:
patent: 3821383 (1974-06-01), Sestanj et al.
patent: 4130714 (1978-12-01), Sarges
Pederson et al.--Abstract No. 321, 25th Meeting of the European Associates for the Study of Diabetes, Sep. 20-23, 1989.
Blohme and Smith--Abstract No. 47, 25th Annual Meeting of the European Associates for the Study of Diabetes, Sep. 20-23, 1989.
The Sorbinil Neuropathy Study Group--Abstract No. 55, Diabetes 38, May 1989.
Jaspan et al.--Abstract No. 56, Diabetes 38, May 1989.
Corsi et al., J. Med. Chem., vol. 19, pp. 778-783 (1976).
Wynganiden et al., Textbook of Medicine 16th edition, pp. 1061-1065, Nov. 1983.
Shibakawa et al., Current Chemotherapy and Infectious Disease, Proc. 11th ICC and 19th ICAAC, Am. Soc. of Microbiol., pp. 469-470, May 1980.
Mylari Banavara L.
Zembrowski William J.
Benson Gregg C.
Brokke Mervin E.
Fan Jane T.
Pfizer Inc.
Richardson Peter C.
LandOfFree
1H-indazole-3-acetic acids as aldose reductase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1H-indazole-3-acetic acids as aldose reductase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1H-indazole-3-acetic acids as aldose reductase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2243984